Lantheus Holdings, Inc. Operating Lease, Liability, Noncurrent
Lantheus Holdings, Inc. (LNTH) had Operating Lease, Liability, Noncurrent of $53.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $53.91M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $55.34M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $50.02M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $50.63M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $53.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $55.34M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $50.02M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $50.63M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $47.85M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $47.56M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $53.19M 10-K · filed 2026-02-26 |
| 2024-09-30 | $53.91M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $54.13M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $54.12M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $54.45M 10-K · filed 2025-02-26 |
| 2023-09-30 | $54.42M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $31.25M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $24.79M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $25.44M 10-K · filed 2024-02-22 |
| 2022-09-30 | $15.35M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $15.78M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $16.21M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $16.55M 10-K · filed 2023-02-23 |
| 2021-09-30 | $16.39M 10-Q · filed 2021-11-04 |
| 2020-12-31 | $17.50M 10-K · filed 2022-02-24 |
| 2019-12-31 | $812.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $862.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $910.00K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $958.00K 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |